Allostery and compartmentalization: Old but not forgotten

Current Opinion in Microbiology

Volumn 18, Issue 1, 2014, Pages 23-29

  Eoh, Hyungjin ^a   Rhee, Kyu Y ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CHEMOKINE RECEPTOR CCR5; DNA BINDING PROTEIN; EFAVIRENZ; G PROTEIN COUPLED RECEPTOR; MARAVIROC; PHOSPHOGLYCERATE DEHYDROGENASE; TUBERCULOSTATIC AGENT;

ALLOSTERISM; BACTERIAL VIRULENCE; BINDING SITE; BIOSYNTHESIS; CELL COMPARTMENTALIZATION; CELL CYCLE; CITRIC ACID CYCLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ESCHERICHIA COLI; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HYDROPHOBICITY; MACROPHAGE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEUROSPORA CRASSA; NONHUMAN; PERMEABILITY BARRIER; PHAGOSOME; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ALLOSTERIC REGULATION; CELL COMPARTMENTATION; MYCOBACTERIUM TUBERCULOSIS; STRESS, PHYSIOLOGICAL;

EID: 84896753299     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.01.007     Document Type: Review

References (57)

1. Monod J., Changeux J.P., Jacob F. Allosteric proteins and cellular control systems. J Mol Biol 1963, 6:306-329.
2. Sprang S.R., Acharya K.R., Goldsmith E.J., Stuart D.I., Varvill K., Fletterick R.J., Madsen N.B., Johnson L.N. Structural changes in glycogen phosphorylase induced by phosphorylation. Nature 1988, 336:215-221.
3. Changeux J.P. Allostery and the Monod-Wyman-Changeux model after 50 years. Annu Rev Biophys 2012, 41:103-133.
4. Raviglione M., Marais B., Floyd K., Lonnroth K., Getahun H., Migliori G.B., Harries A.D., Nunn P., Lienhardt C., Graham S., et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012, 379:1902-1913.
5. Barry C.E., Boshoff H.I., Dartois V., Dick T., Ehrt S., Flynn J., Schnappinger D., Wilkinson R.J., Young D. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009, 7:845-855.
6. Nathan C. Taming tuberculosis: a challenge for science and society. Cell Host Microbe 2009, 5:220-224.
7. Nathan C., Gold B., Lin G., Stegman M., de Carvalho L.P., Vandal O., Venugopal A., Bryk R. A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis. Tuberculosis (Edinb) 2008, 88(Suppl. 1):S25-S33.
8. Russell D.G., Barry C.E., Flynn J.L. Tuberculosis: what we don't know can, and does, hurt us. Science 2010, 328:852-856.
9. Nussinov R., Tsai C.J., Ma B. The underappreciated role of allostery in the cellular network. Annu Rev Biophys 2013, 42:169-189.
10. Huang Z., Mou L., Shen Q., Lu S., Li C., Liu X., Wang G., Li S., Geng L., Liu Y., Wu J., et al. ASD v2.0: updated content and novel features focusing on allosteric regulation. Nucleic Acids Res 2014, 42(1):D510-D516.
11. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
12. Yonetani T., Kanaori K. How does hemoglobin generate such diverse functionality of physiological relevance?. Biochim Biophys Acta 2013, 1834:1873-1884.
13. Nussinov R., Tsai C.J. Allostery in disease and in drug discovery. Cell 2013, 153:293-305.
14. Adkins J.C., Noble S. Efavirenz. Drugs 1998, 56:1055-1064. discussion 1065-1066.
15. Smith N.J., Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 2010, 62:701-725.
16. Wood M.R., Hopkins C.R., Brogan J.T., Conn P.J., Lindsley C.W. 'Molecular switches' on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry 2011, 50:2403-2410.
17. Boshoff H.I., Barry C.E. Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol 2005, 3:70-80.
18. Rustad T.R., Sherrid A.M., Minch K.J., Sherman D.R. Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol 2009, 11:1151-1159.
19. Wayne L.G., Hayes L.G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 1996, 64:2062-2069.
20. Rao S.P., Alonso S., Rand L., Dick T., Pethe K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2008, 105:11945-11950.
21. Weinstein E.A., Yano T., Li L.S., Avarbock D., Avarbock A., Helm D., McColm A.A., Duncan K., Lonsdale J.T., Rubin H. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc Natl Acad Sci U S A 2005, 102:4548-4553.
22. Grant G.A. Contrasting catalytic and allosteric mechanisms for phosphoglycerate dehydrogenases. Arch Biochem Biophys 2012, 519:175-185.
23. Burton R.L., Chen S., Xu X.L., Grant G.A. Role of the anion-binding site in catalysis and regulation of Mycobacterium tuberculosis d-3-phosphoglycerate dehydrogenase. Biochemistry 2009, 48:4808-4815.
24. Burton R.L., Chen S., Xu X.L., Grant G.A. A novel mechanism for substrate inhibition in Mycobacterium tuberculosis d-3-phosphoglycerate dehydrogenase. J Biol Chem 2007, 282:31517-31524.
25. Bentley R. The shikimate pathway-a metabolic tree with many branches. Crit Rev Biochem Mol Biol 1990, 25:307-384.
26. Tribe D.E., Camakaris H., Pittard J. Constitutive and repressivle enzymes of the common pathway of aromatic biosynthesis in Escherichia coli K-12: regulation of enzyme synthesis at different growth rates. J Bacteriol 1976, 127:1085-1097.
27. Hoffmann P.J., Doy C.H., Catcheside D.E. The separation of three allosterically inhibitable 3-deoxy-d-arabino-heptulosonate 7-phosphate synthases from extracts of Neurospora crassa and the purification of the tyrosine inhibitable isoenzyme. Biochim Biophys Acta 1972, 268:550-561.
28. Hartmann M., Schneider T.R., Pfeil A., Heinrich G., Lipscomb W.N., Braus G.H. Evolution of feedback-inhibited beta/alpha barrel isoenzymes by gene duplication and a single mutation. Proc Natl Acad Sci U S A 2003, 100:862-867.
29. Blackmore N.J., Reichau S., Jiao W., Hutton R.D., Baker E.N., Jameson G.B., Parker E.J. Three sites and you are out: ternary synergistic allostery controls aromatic amino acid biosynthesis in Mycobacterium tuberculosis. J Mol Biol 2013, 425:1582-1592.
30. Webby C.J., Jiao W., Hutton R.D., Blackmore N.J., Baker H.M., Baker E.N., Jameson G.B., Parker E.J. Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis. J Biol Chem 2010, 285:30567-30576.
31. de Carvalho L.P., Zhao H., Dickinson C.E., Arango N.M., Lima C.D., Fischer S.M., Ouerfelli O., Nathan C., Rhee K.Y. Activity-based metabolomic profiling of enzymatic function: identification of Rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase. Chem Biol 2010, 17:323-332.
32. Wagner T., Bellinzoni M., Wehenkel A., O'Hare H.M., Alzari P.M. Functional plasticity and allosteric regulation of alpha-ketoglutarate decarboxylase in central mycobacterial metabolism. Chem Biol 2011, 18:1011-1020.
33. Balakrishnan A., Jordan F., Nathan C.F. Influence of allosteric regulators on individual steps in the reaction catalyzed by Mycobacterium tuberculosis 2-hydroxy-3-oxoadipate synthase. J Biol Chem 2013, 288:21688-21702.
34. O'Hare H.M., Duran R., Cervenansky C., Bellinzoni M., Wehenkel A.M., Pritsch O., Obal G., Baumgartner J., Vialaret J., Johnsson K., et al. Regulation of glutamate metabolism by protein kinases in mycobacteria. Mol Microbiol 2008, 70:1408-1423.
35. Villarino A., Duran R., Wehenkel A., Fernandez P., England P., Brodin P., Cole S.T., Zimny-Arndt U., Jungblut P.R., Cervenansky C., et al. Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions. J Mol Biol 2005, 350:953-963.
36. Ames G.F. Bacterial periplasmic transport systems: structure, mechanism, and evolution. Annu Rev Biochem 1986, 55:397-425.
37. Cameron J.C., Wilson S.C., Bernstein S.L., Kerfeld C.A. Biogenesis of a bacterial organelle: the carboxysome assembly pathway. Cell 2013, 155:1131-1140.
38. Ovadi J., Srere P.A. Macromolecular compartmentation and channeling. Int Rev Cytol 2000, 192:255-280.
39. Morgunov I., Srere P.A. Interaction between citrate synthase and malate dehydrogenase. Substrate channeling of oxaloacetate. J Biol Chem 1998, 273:29540-29544.
40. Srere P.A., Ovadi J. Enzyme-enzyme interactions and their metabolic role. FEBS Lett 1990, 268:360-364.
41. Srere P.A. Channeling: the pathway that cannot be beaten. J Theor Biol 1991, 152:23.
42. Narayanaswamy R., Levy M., Tsechansky M., Stovall G.M., O'Connell J.D., Mirrielees J., Ellington A.D., Marcotte E.M. Widespread reorganization of metabolic enzymes into reversible assemblies upon nutrient starvation. Proc Natl Acad Sci U S A 2009, 106:10147-10152.
43. Gill W.P., Harik N.S., Whiddon M.R., Liao R.P., Mittler J.E., Sherman D.R. A replication clock for Mycobacterium tuberculosis. Nat Med 2009, 15:211-214.
44. Hett E.C., Rubin E.J. Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev 2008, 72:126-156. table of contents.
45. Cook G.M., Berney M., Gebhard S., Heinemann M., Cox R.A., Danilchanka O., Niederweis M. Physiology of mycobacteria. Adv Microb Physiol 2009, 55:81-182. 318-319.
46. Nguyen L., Thompson C.J. Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol 2006, 14:304-312.
47. Converse S.E., Mougous J.D., Leavell M.D., Leary J.A., Bertozzi C.R., Cox J.S. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc Natl Acad Sci U S A 2003, 100:6121-6126.
48. Jain M., Cox J.S. Interaction between polyketide synthase and transporter suggests coupled synthesis and export of virulence lipid in M. tuberculosis. PLoS Pathog 2005, 1:e2.
49. Rosenkrands I., Rasmussen P.B., Carnio M., Jacobsen S., Theisen M., Andersen P. Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells. Infect Immun 1998, 66:2728-2735.
50. Kerfeld C.A., Heinhorst S., Cannon G.C. Bacterial microcompartments. Annu Rev Microbiol 2010, 64:391-408.
51. Tanaka S., Sawaya M.R., Yeates T.O. Structure and mechanisms of a protein-based organelle in Escherichia coli. Science 2010, 327:81-84.
52. 2 fixation in cyanobacteria and some proteobacteria. Microbiol Mol Biol Rev 2013, 77:357-379.
53. Chen A.H., Robinson-Mosher A., Savage D.F., Silver P.A., Polka J.K. The bacterial carbon-fixing organelle is formed by shell envelopment of preassembled cargo. PLoS ONE 2013, 8:e76127.
54. Sutter M., Boehringer D., Gutmann S., Gunther S., Prangishvili D., Loessner M.J., Stetter K.O., Weber-Ban E., Ban N. Structural basis of enzyme encapsulation into a bacterial nanocompartment. Nat Struct Mol Biol 2008, 15:939-947.
55. de Carvalho L.P., Fischer S.M., Marrero J., Nathan C., Ehrt S., Rhee K.Y. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 2010, 17:1122-1131.
56. Kuhner S., van Noort V., Betts M.J., Leo-Macias A., Batisse C., Rode M., Yamada T., Maier T., Bader S., Beltran-Alvarez P., et al. Proteome organization in a genome-reduced bacterium. Science 2009, 326:1235-1240.
57. Orsak T., Smith T.L., Eckert D., Lindsley J.E., Borges C.R., Rutter J. Revealing the allosterome: systematic identification of metabolite-protein interactions. Biochemistry 2012, 51:225-232.